Investing

Xenon Pharmaceuticals : XENE

XENE

Stock Data

$56.13

$0.09 (0.16%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Xenon Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for neurological disorders. Based in Canada, it works on innovative therapeutics, including XEN496 and XEN1101, both aimed at treating various forms of epilepsy through the modulation of potassium channels. Additionally, it explores NBI-921352, targeting sodium channels for conditions like SCN8A developmental and epileptic encephalopathy. Collaborating with Neurocrine Biosciences, Xenon is advancing its mission to address unmet medical needs in neurology since 1996.

All Xenon Pharmaceuticals Articles

2 Articles

Eric Bleeker | Mar 9, 2026 at 7:00 PM EDT

50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today

Two small-cap biotech names made serious noise today. Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% today, while Relmada…

Chris MacDonald | Jan 20, 2026 at 10:42 AM EST

3 Biotech Stocks That Could Double In 2026

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors…